Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer

Current Medical Research and Opinion

Volumn 19, Issue 2, 2003, Pages 131-134

  Singh Ranger, G ^a   Kirkpatrick, K L ^a   Clark, G M ^a   Mokbel, Kefah ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b The Princess Grace Hospital   (United Kingdom)

Author keywords

Aromatase; Breast cancer; COX 2; Oestrogen receptor; Progesterone receptor

Indexed keywords

AROMATASE; CYCLOOXYGENASE 2; DNA; ESTROGEN RECEPTOR; LIGAND; MESSENGER RNA; PROGESTERONE RECEPTOR; TELOMERASE;

ANEUPLOIDY; ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL CYCLE S PHASE; DIPLOIDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIGAND BINDING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

BREAST NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PILOT PROJECTS; PLOIDIES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROGESTERONE; RNA, MESSENGER; S PHASE; TELOMERASE;

EID: 0037622029     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079903125001569     Document Type: Article

References (14)

1. Singh-Ranger G, Mokbel K. Role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition. Eur J Surg Oncol 2002;28:729-37
2. Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002;62(3):632-5
3. Kirkpatrick K, Ogunkolade W, Elkak A, Bustin S, Jenkins P, Ghilchik M, Mokbel K. The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin 2002;18(4):237-41
4. Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA. Cyclooxygenase expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 2002;62(6):1676-81
5. Osborne CK. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 1998;51 (3):227-38
6. Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM. Correlation of aromatase and cyclooxygenase expression in human breast cancer specimens. Cancer Lett 1999;140(1-2):27-35
7. Kang HS, Youn YK, Oh SK, Chloe KJ, Noh DY. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer. Breast Cancer Res Treat 2000;63(1):81-7
8. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92(7):550-6
9. Shiao YH, Chen VW, Lehmann HP, Wu XC, Correa P. Patterns of DNA ploidy and S-phase fraction associated with breast cancer survival in blacks and whites. Clin Cancer Res 1997;3(4):587-92
10. Clark GM, Osborne CK, Levitt D, Wu F, Kim NW Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst 1997;89(24):1874-81
11. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988;61:420-7
12. Zhao Y, Agarwal VR, Mendelsohn CR, Simpson ER. Oestrogen biosynthesis proximal to a breast tumour is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP 19 (aromatase) gene. Endocrinology 1996;137(12):5739-42
13. Brodie AM, Lu Q, Long BJ, Fulton A, Chen T, Macpherson N, et al. Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol 2001;79(1-5):41-7
14. Miller WR. Aromatase activity in breast tissue. J Steroid Biochem Mol Biol 1991;39(5B):783-90